Artemether and Lumefantrine Tablets
Description
Fedelty Health Care offers high-quality Artemether and Lumefantrine Tablets, uncoated tablets formulated for oral administration and manufactured according to Indian Pharmacopoeia (IP) and United States Pharmacopeia (USP) standards. Each tablet contains 80mg of Artemether and 480mg of Lumefantrine, a fixed-dose combination widely used as an effective antimalarial treatment, especially against Plasmodium falciparum, including multi-drug resistant strains.
Artemether is a fast-acting artemisinin derivative that rapidly reduces parasite load, while Lumefantrine is a longer-acting antimalarial that helps clear residual parasites, providing a synergistic and effective treatment regimen.
Key Features
- Each uncoated tablet contains: Artemether 80 mg and Lumefantrine 480 mg.
- Complies with IP and USP quality standards ensuring purity, efficacy, and safety.
- Manufactured in GMP-certified facilities with stringent quality assurance.
- Uncoated, easy-to-swallow tablets with stable formulation and suitable shelf life.
- Bulk supply available for pharmaceutical distributors, hospitals, clinics, and exporters.
Therapeutic Uses
- Treatment of acute uncomplicated malaria caused by Plasmodium falciparum including drug-resistant strains.
- Recommended by WHO as a first-line artemisinin-based combination therapy (ACT).
- Effective in reducing parasite load quickly while preventing recrudescence with longer-acting Lumefantrine.
- Suitable for use in endemic regions requiring WHO-prequalified antimalarial therapies.
Dosage & Administration
- Tablets should be taken with food or a fatty meal or milk to enhance absorption.
- The typical adult dose is 80mg Artemether + 480mg Lumefantrine twice daily for three days.
- In case of vomiting within one hour of oral administration, a repeat dose is advised.
- Pediatric dosing varies by weight and age, with appropriate reduced tablet strengths or dispersible formulations preferred for young children.
- Complete the full course for effective cure and prevention of drug resistance.
Packaging
- Tablets are often yellow-colored, circular, flat-faced, uncoated, with bevelled edges, and a break line on one side for easy splitting.
- Supplied in tamper-evident blister packs sized for a full three-day course.
- Packaging designed to protect the product’s integrity throughout its shelf life.
Why Choose Fedelty Health Care?
- Experienced manufacturer and exporter of high-quality antimalarial pharmaceuticals.
- Strict GMP compliance ensuring internationally accepted product quality.
- Competitive pricing with flexible bulk supply and export logistics.
- Reliable product consistency supported by rigorous batch testing and regulatory documentation.
- Commitment to supporting global malaria control efforts with safe and effective medications.
Fedelty Health Care is a reputed manufacturer and exporter of Artemether and Lumefantrine Tablets (Uncoated), a first-line antimalarial treatment recommended by the World Health Organization (WHO) for Plasmodium falciparum infections, including drug-resistant strains.
This combination therapy provides a potent and fast-acting solution against acute uncomplicated malaria and is widely used in tropical and subtropical regions with high malaria transmission.
Manufacturing Standards:
Produced in WHO-GMP accredited manufacturing units, ensuring international quality and regulatory compliance for global supply.
Global Export Expertise:
We cater to bulk procurement, government tenders, NGO medical programs, and international distributors across Africa, Latin America, Asia, and CIS countries.
Packaging Options:
Available in blister packs, mono-cartons, or custom export-ready packaging as per client requirements.
For bulk orders, quotations, or more information about Artemether and Lumefantrine Tablets, contact Fedelty Health Care, your trusted pharmaceutical manufacturing and export partner in quality antimalarial medications.
